drugset / Trial / NCT02265289
Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
To assess the influence of 75 mg Clopidogrel on the pharmacodynamics and safety of 30 mg Lefradafiban tid
Timeline
- Start
- 1999-01
- Primary completion
- 1999-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Lefradafiban | Small molecule | 30 mg | Oral |
Indications
No indication recorded.